Anthem invests Rs.150 cr for its new synthesis fermentation manufacturing unit – Pharmabiz

Anthem Biosciences has invested Rs.150 crore for its new synthesis and fermentation manufacturing facility which will be commissioned in mid 2015. The company which is a dedicated contract research and innovation service (CRIS) provider has been on the radar of global pharma majors looking to offload their assignments to India based on high quality standards and adherence to delivery timelines.

The company’s Greenfield project at the Harohalli Industrial Area in Kanakapura, Bengaluru is its second unit which will focus on chemical synthesis and fermentation manufacturing on large scale. The build-up of orders from international customers led us to expand. The new facility will cater to much of the orders for large scale manufacturing, Ajay Bharadwaj, chief executive officer, Anthem Biosciences Pvt. Ltd told Pharmabiz in a telecon.

Read more – Pharmabiz